Table I.
Characteristics | n (% of the total) |
---|---|
Age (yr) | |
Up to 10 | 23 (2.0) |
11-20 | 186 (15.8) |
21-30 | 229 (19.5) |
31-40 | 244 (20.8) |
41-50 | 204 (17.4) |
51-60 | 181 (15.4) |
Above 60 | 108 (9.2) |
Sex | |
Male | 746 (63.5) |
Female | 429 (36.5) |
Reason for testing | |
Had symptoms | 579 (49.3) |
Contact is positive/symptomatic | 169 (14.4) |
Group testing at workplace/residence | 298 (25.4) |
Travel related | 130 (11.1) |
Medical reasons | 51 (4.3) |
Others | 52 (4.4) |
Comorbidity | |
Yes | 234 (19.9) |
No | 941 (80.1) |
Comorbid conditions | |
Diabetes | 132 (11.2) |
Hypertension | 116 (9.9) |
Heart disease | 17 (1.4) |
Asthma | 14 (1.2) |
Chronic kidney disease | 4 (0.3) |
Cancer | 2 (0.2) |
Vaccination status (n=1043) | |
Unvaccinated | 141 (13.5) |
One dose (<21 days) | 2 (0.2) |
Partially vaccinated (valid one dose) | 148 (14.2) |
Two dose (<14 days) | 41 (3.9) |
Fully vaccinated (valid two doses) | 703 (67.4) |
Three doses | 8 (0.8) |
Symptom status | |
Yes | 758 (64.5) |
No | 417 (35.5) |
Fever | 508 (43.2) |
Body pain | 275 (23.4) |
Running nose | 261 (22.2) |
Cough | 249 (21.2) |
Sore throat | 202 (17.2) |
Headache | 163 (13.9) |
Diarrhoea | 25 (2.1) |
Shortness of breath | 13 (1.1) |